MENU
HALO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Halozyme Therapeutics (HALO) Earnings Date & Reports

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

HALO is expected to report earnings to rise 13.12% to $1.81 per share on August 11

Halozyme Therapeutics HALO Stock Earnings Reports
Q2'26
Est.
$1.81
Q1'26
Beat
by $0.06
Q4'25
Missed
by $2.14
Q3'25
Beat
by $0.11
Q2'25
Beat
by $0.30
The last earnings report on May 11 showed earnings per share of $1.60, beating the estimate of $1.54. With 984.32K shares outstanding, the current market capitalization sits at 9.03B.
View a ticker or compare two or three
HALO
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of recombinant human enzymes for the infertility, ophthalmology and oncology markets

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
12390 El Camino Real
Phone
+1 858 794-8889
Employees
423
Web
https://www.halozyme.com